期刊名：Diabetology

期刊主页：https://www.mdpi.com/journal/diabetology

导语：

糖尿病，作为一种以慢性高血糖为特征的代谢性疾病，严重威胁全球健康，其治疗技术的革新至关重要。传统治疗手段在控糖方面存在一定局限，难以从根本上扭转糖尿病的病理进程。因此，新型治疗技术成为科研与临床关注焦点。该文献清单梳理了多篇聚焦糖尿病新型治疗技术的文献，旨在为相关领域的科研人员、临床医生以及关注糖尿病治疗进展的各界人士，提供全面且深入的研究资料，助力推动糖尿病治疗技术迈向新高度，改善全球糖尿病患者的生活质量与预后。

正文部分：

1. Managing Hospitalized Patients Taking SGLT2 Inhibitors: Reducing the Risk of Euglycemic Diabetic Ketoacidosis

住院患者 SGLT2 抑制剂用药管理：降低正常血糖性糖尿病酮症酸中毒风险

https://www.mdpi.com/2673-4540/4/1/10

2. Advanced Technology (Continuous Glucose Monitoring and Advanced Hybrid Closed-Loop Systems) in Diabetes from the Perspective of Gender Differences

糖尿病领域先进技术（连续血糖监测与高级混合闭环系统）的性别差异视角研究

https://www.mdpi.com/2673-4540/4/4/45

3. Melanocortins and Their Potential for the Treatment, Prevention and Amelioration of Complications of Diabetes

黑素皮质素在糖尿病治疗、预防及并发症改善中的潜力

https://www.mdpi.com/2673-4540/5/1/6

4. Exosome-Derived microRNAs: Bridging the Gap Between Obesity and Type 2 Diabetes in Diagnosis and Treatment

外泌体衍生微小 RNA：衔接肥胖与 2 型糖尿病诊疗的桥梁

https://www.mdpi.com/2673-4540/5/7/52

5. Does the Efficacy of Semaglutide Treatment Differ between Low-Risk and High-Risk Subgroups of Patients with Type 2 Diabetes and Obesity Based on SCORE2, SCORE2-Diabetes, and ASCVD Calculations?

基于 SCORE2、SCORE2 - 糖尿病及 ASCVD 评分的 2 型糖尿病合并肥胖患者中，司美格鲁肽疗效在高低风险亚组间的差异？

https://www.mdpi.com/2673-4540/5/1/3

6. Exploration of Foundational Models for Blood Glucose Forecasting in Type-1 Diabetes Pediatric Patients

1 型糖尿病儿童患者血糖预测基础模型的探索

https://www.mdpi.com/2673-4540/5/6/42

7. Impact of Hypoglycemia on Glucose Variability over Time for Individuals with Open-Source Automated Insulin Delivery Systems

开源自动胰岛素输注系统使用者中，低血糖对长期血糖变异性的影响

https://www.mdpi.com/2673-4540/5/5/38

8. Evaluation of Insulin Secretion and Continuous Glucose Monitoring in Patients with Cystic Fibrosis After Initiation of Transmembrane Conductance Regulator Modulator: A 52-Week Prospective Study

跨膜传导调节因子调节剂启动后，囊性纤维化患者胰岛素分泌及连续血糖监测的 52 周前瞻性评估

https://www.mdpi.com/2673-4540/5/6/40

Diabetology 期刊介绍

主编：Prof. Dr. Peter Clifton, University of South Australia, , Australia

期刊主题涵盖糖尿病的流行病学、病因学、病理生理学、发病机制、临床管理、并发症、预防策略，以及疾病相关的分子、生化与生理机制等多个研究领域。目前已被 SCIE（Web of Science）、Scopus 等国际权威数据库收录。

欢迎浏览Diabetology期刊高引文章：

https://www.mdpi.com/journal/diabetology/most_cited